How levosimendan can improve renal function?

How levosimendan can improve renal function?

Bibliographic Details
Main Authors:	Patrick M. Honore, Leonel Barreto Gutierrez, Sebastien Redant, Keitiane Kaefer, Andrea Gallerani, David De Bels
Format:	Article
Language:	English
Published:	BMC 2019-10-01
Series:	Critical Care
Online Access:	http://link.springer.com/article/10.1186/s13054-019-2642-z

Similar Items

Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights
by: Patrick M. Honore, et al.
Published: (2019-12-01)

What should be the best dialysis catheter lock in critically ill patients?
by: Patrick M. Honore, et al.
Published: (2019-10-01)

Obesity inducing acute respiratory distress syndrome: we should choose the right population!
by: Patrick M. Honore, et al.
Published: (2019-10-01)

Biomarker suPAR seems a good prognostic factor for community-acquired pneumonia but less prominent for septic shock
by: Patrick M. Honore, et al.
Published: (2019-12-01)

Dysbiosis of the microbiota in neurocritically ill patients associated with coma and death: ammonia as a potential missing link
by: Patrick M. Honore, et al.
Published: (2019-12-01)

Interleukin-26 is a promising biomarker of sepsis but is it always reliable?
by: Patrick M. Honore, et al.
Published: (2019-12-01)

High levels of plasma biomarkers at 24 h were found to be strong predictors of 90-day mortality: beware of some potential confounders!
by: Patrick M. Honore, et al.
Published: (2021-03-01)

Higher incidence of arrhythmia in COVID-19 than in other community-acquired pneumonia: possible role of concurrent therapies
by: Patrick M. Honore, et al.
Published: (2021-07-01)

Success rate of naso-jejunal tube placement influenced by CRRT: possible removal of metoclopramide
by: Patrick M. Honore, et al.
Published: (2021-06-01)

Prophylactic use of levosimendan in pediatric patients undergoing cardiac surgery: the jury is still out
by: Xavier Beretta-Piccoli, et al.
Published: (2020-03-01)

Early latency evoked potentials can no longer be considered an infallible predictor of neurologic outcome
by: Patrick M. Honore, et al.
Published: (2020-06-01)

Infliximab can reduce mortality from 35 to 14% in critically ill patients with COVID-19: perhaps some potential confounders to consider
by: Patrick M. Honore, et al.
Published: (2020-10-01)

Liver injury without liver failure in COVID-19 patients: how to explain, in some cases, elevated ammonia without hepatic decompensation
by: Patrick M. Honore, et al.
Published: (2020-06-01)

Plasma exchange in critically ill COVID-19 patients improved inflammation, microcirculatory clot formation, and hypotension, thereby improving clinical outcomes: fact or fiction?
by: Patrick M. Honore, et al.
Published: (2020-09-01)

Patients with emm1/T1 serotype invasive group A streptococci infections demonstrated more renal failure than patients with other serotypes: perhaps we should consider some confounders
by: Patrick M. Honore, et al.
Published: (2020-07-01)

TPE seems to be a treatment that may improve outcomes by effectively removing fibrin degradation products and restoring coagulation status: fact or fiction?
by: Patrick M. Honore, et al.
Published: (2020-10-01)

Icatibant, another piece of the therapeutic puzzle regarding hemodynamic side effects of angiotensin-converting enzyme inhibitors
by: Patrick M. Honore, et al.
Published: (2019-08-01)

Sevoflurane and nephrogenic diabetes insipidus on the rise: copeptin to the rescue?
by: Patrick M. Honore, et al.
Published: (2019-09-01)

Endotoxin removal by polymyxin B: is it a question of dose or duration or both?
by: Patrick M. Honore, et al.
Published: (2019-09-01)

Detecting influenza-associated pulmonary aspergillosis by determination of galactomannan in broncho-alveolar lavage fluid and in serum: should we add (1,3)-beta-D-glucan to improve efficacy
by: Patrick M. Honore, et al.
Published: (2020-06-01)

A retrospective study in adult patients with septic shock and multiple organ failure demonstrated improved 28-day survival with adjunct TPE compared to standard care alone: true effect or mediated by a negative fluid balance achieved by RRT?
by: Patrick M. Honore, et al.
Published: (2020-10-01)

Adsorption and caspofungin dosing during continuous renal replacement therapy
by: Patrick M. Honore, et al.
Published: (2019-07-01)

Endocan removal during continuous renal replacement therapy: does it affect the reliability of this biomarker?
by: Patrick M. Honore, et al.
Published: (2019-05-01)

Treatment of influenza virus-related critical illness during continuous renal replacement therapy: take caution with dosing
by: Patrick M. Honore, et al.
Published: (2020-03-01)

Irrespective of the degree of hyperlactatemia, similar lactate levels were associated with a lower mortality rate in metformin users compared with non-users: beware of confounders!
by: Patrick M. Honore, et al.
Published: (2020-10-01)

Inhibiting IL-6 in COVID-19: we are not sure
by: Patrick M. Honore, et al.
Published: (2020-07-01)

Use of multiple laboratory tests including anti-factor Xa to optimally manage anticoagulation during ECMO
by: Patrick M. Honore, et al.
Published: (2020-07-01)

SARS-CoV-2 infection as a risk factor for herpesviridae reactivation: consider the potential influence of corticosteroid therapy
by: Patrick M. Honore, et al.
Published: (2020-10-01)

High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT?
by: Patrick M. Honore, et al.
Published: (2020-10-01)

Mortality in non-elderly septic patients was increased with hypothermia and decreased with fever while mortality in elderly patients was not associated with body temperature: beware of some confounders!
by: Patrick M. Honore, et al.
Published: (2020-10-01)

Risk of harlequin syndrome during bi-femoral peripheral VA-ECMO: should we pay more attention to the watershed or try to change the venous cannulation site?
by: Patrick M. Honore, et al.
Published: (2020-07-01)

Using indirect calorimetry in place of fixed energy prescription was feasible and energy targets were more closely met: do not forget an important limitation
by: Patrick M. Honore, et al.
Published: (2020-06-01)

Hepcidin is described as the master regulator of iron: could its removal by CRRT lead to iron dysmetabolism in the critically ill?
by: Patrick M. Honore, et al.
Published: (2020-09-01)

Compared to NIPPV, HFNC is more dangerous regarding aerosol dispersion and contamination of healthcare personnel: we are not sure
by: Patrick M. Honore, et al.
Published: (2020-08-01)

Is cortical perfusion a reliable marker for predicting septic acute kidney injury?
by: Patrick M. Honore, et al.
Published: (2019-03-01)

In severe liver disease, citrate can be used safely: the question remains—by which mechanism
by: Patrick M. Honore, et al.
Published: (2020-02-01)

No dose adjustment of tigecycline is necessary during continuous renal replacement therapy: we are not sure
by: Patrick M. Honore, et al.
Published: (2020-02-01)

Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies?
by: Patrick M. Honore, et al.
Published: (2018-11-01)

Vancomycin pharmacokinetics in critically ill obese patients: can the clinician sit back and relax?
by: Patrick M. Honore, et al.
Published: (2019-01-01)

Who may benefit most from future vitamin D intervention trials: do not forget patients on continuous renal replacement therapy
by: Patrick M. Honore, et al.
Published: (2020-04-01)